Skip to content

Our Team of Experts

An experienced team of pharmaceutical professionals from all areas of business expertise lead day-to-day operations at Fidelis.

Our leaders are committed to delivering innovative, high-quality pharmaceutical solutions to fulfill specialized veterinary needs that protect animal welfare and meet the highest standards of care.

MICHAEL WELLS

Chairman and Chief Executive Officer
Fidelis has a bright future with Mike Wells at the helm as executive chairman and CEO. Mike’s extensive pharmaceutical experience and expertise in licensing and commercialization of prescription drugs has already paid off for Fidelis. After just a short time in business, our lead product offering for extended-release pain management is already FDA-indexed and being used by leading research institutions in the U.S., with development of additional extended-release technology products well underway.
Mike concurrently serves as a managing director at Princeton Biopharma Capital Partners, a boutique private-equity firm he founded in 2010 to provide growth capital and operating expertise to commercial-stage healthcare companies. Prior to starting Princeton Biopharma, he was founder and CEO of Aton Pharma, Inc, a specialty pharmaceutical company focused on treating rare diseases. For his part in developing Aton, Mike was recognized as the 2009 Ernst & Young Entrepreneur of the Year.

Mike began his long and distinguished career by gaining eight years of “big pharma” sales and marketing experience at Merck before diving in as a healthcare entrepreneur and investor. His first start-up venture was founding Lathian Systems Inc. to provide online data and marketing services to pharma and biotech companies.

In addition to serving on the Fidelis Board of Directors and as a University of Pittsburgh Trustee, Mike holds board positions with Covis Pharma SARL, Valeo Pharmaceuticals, and PhotoSonix Medical. He earned BS and MS degrees from the University of Pittsburgh and an MBA from The Wharton School.

CYNTHIA DAVIS

Chief Financial Officer
With more than 20 years of experience leading financial operations for pharmaceutical and healthcare company start-ups, Cynthia is right at home directing all facets of finances, accounting, reporting, and operations at Fidelis.
As she oversees Fidelis financial operations in this time of rapid growth, Cynthia draws on her senior-level entrepreneurial experience, most recently as principal and financial lead at Total Bio Solutions consulting for start-up biotech and high-tech enterprise clients. Prior to that, she served as global controller for Quantum Global Technologies, experience she is drawing on as she helps Fidelis expand its reach. for commercialization.

As vice president of finance and treasury and other senior finance positions for The Discovery Labs, she led treasury, special-purpose financing, risk management, and facilities. Additionally, she completed due diligence review for acquisitions and capital expenditures as the biotech company prepared for commercialization.

Holding a BS degree in business administration from Delaware Valley University, Cynthia also puts her skills to good use to support local youth organizations, eg, serving as founder and past chair of the Plumstead (PA) Baseball Association Fundraising and Sponsorships Committee.

STEVEN LEARY, DVM, DACLAM

Chief Medical Officer
A nationally recognized advocate for the humane and continuously improved care of laboratory animals, Steven is the perfect fit to be our chief medical officer. In this role, he guides Fidelis in developing high-quality pain management solutions and supporting research institutions around the country in the successful use of our extended-release technology to benefit laboratory animal welfare.
Steven joined Fidelis after retiring as director of the Division of Comparative Medicine at Washington University in St. Louis. During this 25-year tenure, he provided for the well-being and clinical care of animals at one of the nation’s largest, most complex research institutions and oversaw centralization of the university’s 28 animal care programs and facilities. Previously, Steven also served as a director at the University of Alabama at Birmingham.

Steven earned his DVM degree from Iowa State University and was a postdoctoral fellow in laboratory animal medicine and comparative pathology at Johns Hopkins University. He went on to become a diplomate in the American College of Laboratory Animal Medicine (DACLAM).

To name just a few of his association positions, Steven has served the industry as president of ACLAM, as an AALAC council member, and as chair of the AVMA Animal Welfare Committee. A sought-after speaker, published author, and editorial board member, a few of Steven’s accolades include the Iowa State University’s Stange Award for Meritorious Service in Veterinary Medicine, the Charles River Prize in Laboratory Science and Medicine, and the AALAS Charles A. Griffin and Nathan R. Brewer Lifetime Achievement Awards.

BARRY LEVINSON, PhD

Co-Founder and Chief Development Officer
Barry’s biochemistry background has fueled his lifelong passion for bringing leading-edge healthcare products from conception through to commercialization. As a managing director at Princeton Biopharma Capital, a Fidelis board member, and our chief development officer, Barry has been instrumental in bringing our lead product Ethiqa XR® to research institutions around the country and in securing capital to accelerate additional product development.
Barry’s track record of accomplishments in pharmaceuticals and biotech spans more than 40 years. Prior to co-founding Fidelis, he served as vice president of business development at Valeant Pharma (now Bausch Health) and was a founding vice president (business development) and chief scientific officer at Aton Pharma. His talent and expertise in recognizing new medical uses and spearheading R&D to expand indications was evident at Aton.

Intrigued with entrepreneurship early in his career, Barry began his corporate years at the biotech startup Ecogen. From there, he spent a decade in increasingly senior positions in cardiovascular research and business development for Berlex Labs.

After earning his BA in biochemistry with highest honors from Princeton, Barry went on to earn his MS and PhD degrees in molecular biophysics and biochemistry from Yale University.

ERIC SCHREIBER

Vice President, Sales and Marketing
A believer in “doing what you love,” Eric brings great enthusiasm and a wealth of experience in animal health/pharmaceuticals, sales and marketing, and advertising to his leadership role at Fidelis. He is passionate about bringing high-quality innovations to market to help improve animal care and welfare.
Eric has done just that, with more than 20 new animal health and pharmaceutical product introductions to his credit. His broad animal health commercialization expertise comes from 30+ years working in pharmaceutical sales and marketing roles at Pfizer Animal Health and Wyeth Pharmaceuticals, executive leadership positions with advertising agencies Saatchi & Saatchi and Ogilvy, and as founder and president of Harmony Marketing Partners.

Eric holds a BS in business administration from Bucknell University and has completed graduate executive education programs at The Wharton School of the University of Pennsylvania and the University of Richmond.

KENNETH SYLVESTER, PhD, MBA, RPh

Vice President, Manufacturing and Supply Chain
With more than 30 years of experience leading pharmaceutical manufacturing and global supply chain operations, Ken is a natural to head all facets of Fidelis cGMP-certified manufacturing and supply chain. Ken’s broad range of knowledge keeps our lead product sourcing and production running smoothly and ensures the impeccable quality our clients expect.
Some highlights of Ken’s extensive corporate experience include roles as head of North America external manufacturing for Sanofi, directing worldwide manufacturing for Cephalon, manufacturing supply chain for SmithKline Beecham Pharmaceuticals (GSK), and auditing quality control in pharmaceutical production for Merck.

A registered pharmacist (RPh), Ken brings advanced education in both pharmacy and business management to his position at Fidelis. Ken earned a BS in pharmacy from the Philadelphia College of Pharmacy and Science, an MBA in management from LaSalle University, and a PhD in pharmacy-health policy from the University of the Sciences.

SUSAN WITHAM

Senior Vice President, Regulatory Affairs and Quality
If there ever was a one-source expert for all matters related to pharmaceutical regulatory affairs, quality assurance/quality control, and working with the FDA, Susan Witham is it. Bringing 30+ years of experience in these areas, Susan leads the Fidelis team through all facets of regulatory compliance and quality.
Susan has a strong track record of successful new product applications and has advised a number of companies in regulatory-related matters. Her accomplished pharmaceutical career includes a variety of senior executive roles in regulatory and quality at Kremers Urban Pharmaceuticals (now Lannett), Shionogi Inc, and Adams Respiratory Therapeutics, as well as positions with Columbia Labs, Aventis Pharmaceuticals, Johnson & Johnson Consumer Products, and Novartis. Her expertise and guidance is instrumental as Fidelis continues to develop and expand our pharmaceutical-grade pain management solutions in animal health and welfare. In her role at Fidelis, Susan finds it rewarding to guide the approval of high-quality products that make it easier for research institutions to comply with the latest regulatory guidelines in animal care as well.

Susan holds a BS degree in biology from Bridgewater College in Virginia.

Connect with us

Fidelis is actively seeking new partnerships and product opportunities. If would like to get more information or would like to discuss investment, partnership, or new product development opportunities with the Fidelis leadership team, please contact us below. Thank you for your interest.